Detalles de la búsqueda
1.
Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).
Support Care Cancer
; 24(9): 3847-55, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27075674
2.
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).
Int J Radiat Oncol Biol Phys
; 81(2): 397-402, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20888137
3.
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Int J Radiat Oncol Biol Phys
; 79(5): 1460-6, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20800381
4.
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.
J Clin Oncol
; 28(23): 3673-9, 2010 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20625123
Resultados
1 -
4
de 4
1
Próxima >
>>